New York City-based Mount Sinai Health System has partnered with intelligence platform Onegevity Health to commercialize Lab100, Mount Sinai's technology- and data-driven precision health clinic and research lab.
Lab100 opened in the fall of 2018 at Mount Sinai's Upper East Side location. The hybrid lab uses advanced diagnostic screening tools, digital applications and data science to create a comprehensive health report enabling patients to be proactive in managing their own health. It also provides researchers and innovators with health data to inform the development of preventive treatments.
Under the new partnership, Onegevity will manage Lab100's global licensing, expanding the lab's model of personalized, preventive care to other communities, ultimately resulting in innovative advancements in data-driven care delivery across the U.S., according to Joel Dudley, PhD, director of Mount Sinai's Institute for Next Generation Healthcare and co-founder of Onegevity.
More articles on innovation:
CHLA Innovation Studio announces winners of health tech accelerator
NIH awards $1.7M to grow health tech research and development network
Partners pours $80M into investment funds for digital tech, AI, life sciences